Christina To

4PUBLICATIONS
57CO-AUTHORS
Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 01, 2024
Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume.

Frederick L Locke, Olalekan O Oluwole, John Kuruvilla

|Nov 20, 2023
Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7).

Simone Filosto, Saran Vardhanabhuti, Miguel A Canales

|Aug 01, 2023
Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11.

Michael D Jain, David B Miklos, Caron A Jacobson

|Mar 31, 2023
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma.

Jason R Westin, Frederick L Locke, Michael Dickinson

Pageof 1

Frequent Collaborators

3 joint publications

Simone Filosto

2 joint publications

Jason R Westin

2 joint publications

Frederick L Locke

2 joint publications

Olalekan O Oluwole